glp-1 kidney outcomes news Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic disease A new study from NYU

At the highest dose, clinical trial patients lost about 10 pounds over a 9-month period - so while its not approved for weight loss, it may still have some weight-related benefits

Without the caloric deficit, the injections have no substrate to work on

The side effect profile of direct HGH (water retention, joint pain, insulin resistance at higher doses) is largely absent with CJC-1295/Ipamorelin at clinical doses because the physiological GH pulse is smaller and self-regulated

To view or add a comment, sign in Medicares GLP-1 Bridge goes live today, and with it, a new reference price for this class of drugs that every employer plan will now be measured against